Technical Data
Bcl 2 (B Cell Leukemia 2)
Bcl 2 is an intracellular non-glycosylated protein that was originally identi ed in the analysis of the (14:18) (q32; q21) translocation break point in follicular lymphoma. This translocation results in the juxtaposition of the Bcl 2 gene with the immunoglobulin heavy chain gene locus on chromosome 14. As a result, a high level of Bcl-2 protein is produced. The 26kD Bcl 2 protein is localized on the mitochondrial membrane, nuclear envelope, and endoplasmic reticulum. It regulates cell death, prolonging cell survival by blocking apoptosis which leads to neoplastic growth without affecting cell proliferation.
This antibody stains lymphoid tissues. In normal lymph node and tonsil tissues, Bcl 2 antibody stains B-cells in mantle zone and interfollicular T-cell areas, but the germinal center cells were not immunoreactive. In the thymus, medullary cells are Bcl 2 positive, whereas cortical cells are negative. In the spleen, Bcl 2 expression was found in both B and T cell areas and in the red pulp, but the germinal center cells were not immunoreactive. Peripheral blood lymphocytes were also strongly positive for Bcl 2 reactivity. Thus, the results indicate that Bcl 2 protein is found mainly in non-proliferating small lymphocytes.

Suitable for use in Immunohistochemistry. Other applications not tested.

Recommended Dilutions:
Immunohistochemistry (FFPE): Requires HIER using sodium citrate buffer pH6.0
Optimal dilutions to be determined by the researcher.

Recommended Positive Control Tissue:
Human breast, prostate carcinoma or follicular lymphoma

Storage and Stability:
May be stored at 4C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20C. Aliquots are stable for 12 months after receipt. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
1ml-20CBlue IceHumanMouse
Synthetic peptide corresponding to human Bcl 2 protein. Expected Staining Pattern: Cytoplasmic.
Supplied as a liquid in PBS, pH 7.4, 1% BSA, 0.09% sodium azide.
Recognizes human Bcl-2.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
1. Tsujimoto, H., et al., Science 228: 1440-1443 (1985). 2. Chen-Levy, Z., et al., Mol. Cell Biol 9: 701-710 (1989). 3. Lu, Q.L., et al., Hu. Pathol 27: 102-110 (1996). 4. Korsmeyer, S.J., Blood 80: 879-886 (1992). 5. Reed, J.C., J.Cell Biol. 124: 1-6 (1994). 6. Hockenbery, D.M., et al., Proc. Natl. Acad. Sci. USA 88: 6961-6965 (1991). 7. Takahashi, H., et al., Pathol. Res. Prac. 194: 163-170 (1998). 8. Zutter, M., et al., Blood 78: 1062-1068 (1991). 9. Said, J.W., et al., Appl. Immunohistochem I: 108-114 (1993). 10. Colombel, M., et al., Am. J. Pathol. 143: 390-400 (1993). 11. Gee, J.M.W., et al., Int. J. Cancer 59: 1-6 (1994). 12. Lauwers, G.Y., et al., Cancer 73: 2900-2904 (1994). 13. Pezzella, F., et al., N. Engl. J. Med. 32: 690-694 (1993). 14. Virkajarvi, N., et al., Histopatho. 33: 432-439 (1998). 15. Papatheodoridis, G., et al., Am. J. Gastroentero. 93: 1136-1140 (1998). 16. Eid, H., et al., Cancer 53(2): 331-336 (1998). 17. Skopelitou, A., et al., Anticancer Res 16: 975-978 (1996). 18. Charlotte, F., et al., Am. J. Pathol. 144(3): 460-465 (1994). 19. Frommel, T.O., et al., Am. J. Gastroentero. 94(1): 178-182 (1999). 20. Zhao, M., et al., Histopathol 25: 237-245 (1994). 21. Wu, C.D., et al., Hematopathol 25: 231-245 (1994). 22. Harmsel, B.T., et al., J. Pathol. 179: 26-30 (1996)..